1
|
Wisseh C, Adinkrah E, Opara L, Melone S, Udott E, Bazargan M, Shaheen M. Associations between Diabetes-Specific Medication Regimen Complexity and Cardiometabolic Outcomes among Underserved Non-Hispanic Black Adults Living with Type 2 Diabetes Mellitus. PHARMACY 2024; 12:83. [PMID: 38921959 DOI: 10.3390/pharmacy12030083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2024] [Revised: 05/18/2024] [Accepted: 05/23/2024] [Indexed: 06/27/2024] Open
Abstract
Type 2 diabetes mellitus (T2DM) management and glycemic control in underserved non-Hispanic Black adults presents with multifaceted challenges: balancing the optimal complexity of antihyperglycemic medications prescribed, limited medication access due to socioeconomic status, medication nonadherence, and high prevalence of cardiometabolic comorbidities. This single-center, cross-sectional, retrospective chart analysis evaluated the association of Medication Regimen Complexity (MRC) with cardiometabolic outcomes (glycemic, atherogenic cholesterol, and blood pressure control) among non-Hispanic Black adults with type 2 diabetes. Utilizing 470 independent patient electronic health records, MRC and other covariates were examined to determine their associations with cardiometabolic outcomes. Chi-square tests of independence and multiple logistic regression were performed to identify associations between MRC and cardiometabolic outcomes. Our findings indicate significant negative and positive associations between MRC and glycemic control and atherogenic cholesterol control, respectively. However, there were no associations between MRC and blood pressure control. As diabetes MRC was shown to be associated with poor glycemic control and improved atherogenic cholesterol control, there is a critical need to standardize interdisciplinary diabetes care to include pharmacists and to develop more insurance policy interventions that increase access to newer, efficacious diabetes medications for historically marginalized populations.
Collapse
Affiliation(s)
- Cheryl Wisseh
- Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, CA 92697, USA
- Department of Family Medicine, College of Medicine, Charles R. Drew University of Medicine and Science (CDU), Los Angeles, CA 90059, USA
| | - Edward Adinkrah
- Department of Family Medicine, College of Medicine, Charles R. Drew University of Medicine and Science (CDU), Los Angeles, CA 90059, USA
| | - Linda Opara
- Adult and Children's Psychiatric Outpatient Clinic, Fresno County Department of Behavioral Health, Fresno, CA 93702, USA
| | - Sheila Melone
- Health and Wellness Center, Walmart Pharmacy, Bakersfield, CA 93307, USA
| | - Emem Udott
- Health and Wellness Center, Walmart Pharmacy, Bakersfield, CA 93307, USA
| | - Mohsen Bazargan
- Department of Family Medicine, College of Medicine, Charles R. Drew University of Medicine and Science (CDU), Los Angeles, CA 90059, USA
- Department of Family Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA
| | - Magda Shaheen
- Department of Internal Medicine, College of Medicine, Charles R. Drew University of Medicine and Science (CDU), Los Angeles, CA 90059, USA
| |
Collapse
|
2
|
Wittenauer R, Shah PD, Bacci JL, Stergachis A. Locations and characteristics of pharmacy deserts in the United States: a geospatial study. HEALTH AFFAIRS SCHOLAR 2024; 2:qxae035. [PMID: 38756173 PMCID: PMC11034534 DOI: 10.1093/haschl/qxae035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 01/29/2024] [Revised: 03/12/2024] [Accepted: 03/14/2024] [Indexed: 05/18/2024]
Abstract
Pharmacies are important health care access points, but no national map currently exists of where pharmacy deserts are located. This cross-sectional study used pharmacy address data and Census Bureau surveys to define pharmacy deserts at the census tract level in all 50 US states and the District of Columbia. We also compared sociodemographic characteristics of pharmacy desert vs non-pharmacy desert communities. Nationally, 15.8 million (4.7%) of all people in the United States live in pharmacy deserts, spanning urban and rural settings in all 50 states. On average, communities that are pharmacy deserts have a higher proportion of people who have a high school education or less, have no health insurance, have low self-reported English ability, have an ambulatory disability, and identify as a racial or ethnic minority. While, on average, pharmacies are the most accessible health care setting in the United States, many people still do not have access to them. Further, the people living in pharmacy deserts are often marginalized groups who have historically faced structural barriers to health care. This study demonstrates a need to improve access to pharmacies and pharmacy services to advance health equity.
Collapse
Affiliation(s)
- Rachel Wittenauer
- CHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA 98195, United States
| | - Parth D Shah
- Hutchinson Institute for Cancer Outcomes Research (HICOR), Fred Hutchinson Cancer Center, Seattle, WA 98109, United States
| | - Jennifer L Bacci
- CHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA 98195, United States
| | - Andy Stergachis
- CHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA 98195, United States
- Department of Global Health, School of Public Health, University of Washington, Seattle, WA 98105, United States
| |
Collapse
|
3
|
Zheutlin AR, Sharareh N, Guadamuz JS, Berchie RO, Derington CG, Jacobs JA, Mondesir FL, Alexander GC, Levitan EB, Safford M, Vos RO, Qato DM, Bress AP. Association Between Pharmacy Proximity With Cardiovascular Medication Use and Risk Factor Control in the United States. J Am Heart Assoc 2024; 13:e031717. [PMID: 38390820 PMCID: PMC10944071 DOI: 10.1161/jaha.123.031717] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/10/2023] [Accepted: 01/16/2024] [Indexed: 02/24/2024]
Abstract
BACKGROUND Poor neighborhood-level access to health care, including community pharmacies, contributes to cardiovascular disparities in the United States. The authors quantified the association between pharmacy proximity, antihypertensive and statin use, and blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) among a large, diverse US cohort. METHODS AND RESULTS A cross-sectional analysis of Black and White participants in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study during 2013 to 2016 was conducted. The authors designated pharmacy proximity by census tract using road network analysis with population-weighted centroids within a 10-minute drive time, with 5- and 20-minute sensitivity analyses. Pill bottle review measured medication use, and BP and LDL-C were assessed using standard methods. Poisson regression was used to quantify the association between pharmacy proximity with medication use and BP control, and linear regression for LDL-C. Among 16 150 REGARDS participants between 2013 and 2016, 8319 (51.5%) and 8569 (53.1%) had an indication for antihypertensive and statin medication, respectively, and pharmacy proximity data. The authors did not find a consistent association between living in a census tract with higher pharmacy proximity and antihypertensive medication use, BP control, or statin medication use and LDL-C levels, regardless of whether the area was rural, suburban, or urban. Results were similar among the 5- and 20-minute drive-time analyses. CONCLUSIONS Living in a low pharmacy proximity census tract may be associated with antihypertensive and statin medication use, or with BP control and LDL-C levels. Although, in this US cohort, outcomes were similar for adults living in high or low pharmacy proximity census tracts.
Collapse
Affiliation(s)
- Alexander R. Zheutlin
- Division of Cardiology, Feinberg School of MedicineNorthwestern UniversityChicagoILUSA
| | - Nasser Sharareh
- Department of Population Health Sciences, Spencer Fox Eccles School of MedicineUniversity of UtahSalt Lake CityUTUSA
| | - Jenny S. Guadamuz
- Division of Health Policy and ManagementUniversity of California, Berkeley, School of Public HealthBerkeleyCAUSA
| | - Ransmond O. Berchie
- Department of Population Health Sciences, Spencer Fox Eccles School of MedicineUniversity of UtahSalt Lake CityUTUSA
| | - Catherine G. Derington
- Department of Population Health Sciences, Spencer Fox Eccles School of MedicineUniversity of UtahSalt Lake CityUTUSA
| | - Joshua A. Jacobs
- Department of Population Health Sciences, Spencer Fox Eccles School of MedicineUniversity of UtahSalt Lake CityUTUSA
| | - Favel L. Mondesir
- Department of EpidemiologyUniversity of Alabama at Birmingham School of Public HealthBirminghamALUSA
| | - G. Caleb Alexander
- Department of EpidemiologyCenter for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public HealthBaltimoreMDUSA
- Department of MedicineJohns Hopkins MedicineBaltimoreMDUSA
| | - Emily B. Levitan
- Department of EpidemiologyUniversity of Alabama at Birmingham School of Public HealthBirminghamALUSA
| | - Monika Safford
- Division of General Internal Medicine, Department of Medicine, Weill Cornell Medical CollegeCornell UniversityNew YorkNYUSA
| | - Robert O. Vos
- Spatial Sciences Institute, Dornsife College of Letters, Arts, and SciencesUniversity of Southern CaliforniaLos AngelesCAUSA
| | - Dima M. Qato
- Spatial Sciences Institute, Dornsife College of Letters, Arts, and SciencesUniversity of Southern CaliforniaLos AngelesCAUSA
- Program on Medicines and Public Health, Titus Family Department of Clinical Pharmacy, School of Pharmacy, University of Southern CaliforniaLos AngelesCAUSA
- Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern CaliforniaLos AngelesCAUSA
- Program on Medicines and Public Health, Alfred Mann School of Pharmacy and Pharmaceutical SciencesUniversity of Southern CaliforniaLos AngelesCAUSA
| | - Adam P. Bress
- Department of Population Health Sciences, Spencer Fox Eccles School of MedicineUniversity of UtahSalt Lake CityUTUSA
| |
Collapse
|
4
|
Jackson JK, Chaar BB, Kirkpatrick CM, Scahill SL, Mintrom M. A Qualitative Evaluation of the Australian Community Pharmacy Agreement. PHARMACY 2023; 11:188. [PMID: 38133463 PMCID: PMC10747587 DOI: 10.3390/pharmacy11060188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2023] [Revised: 12/09/2023] [Accepted: 12/11/2023] [Indexed: 12/23/2023] Open
Abstract
The Australian Federal Government's Community Pharmacy Agreement (Agreement), initiated in 1990 and renegotiated every five years with a pharmacy owners' organisation, is the dominant policy directing community pharmacy. We studied the experience with the Agreements of 38 purposively selected individual pharmacists and others of diverse backgrounds, using in-depth, semi-structured interviews. Although perceived to lack transparency in negotiation and operation, as well as paucity of outcome measures, the Agreements have generally supported the viability of community pharmacies and on balance, contributed positively to the public's access to medicines. There were, however, contradictory opinions regarding the impact of the policy's regulation of pharmacy locations, including the suggestion that they provide existing owners with an undue commercial advantage. A reported shortcoming of the Agreements was their impact on pharmacists' abilities to expand their scopes of practice and assist patients to make better use of medicines, in part due to the funding being almost totally focused on supply-related functions. The support for programs such as medication management services was perceived to be limited, and opportunities for diversification in pharmacy practice appeared constrained. Future pharmacy policy developed by the government could be more inclusive of a diverse range of stakeholders, seek to better utilise pharmacists' expertise, and have a greater focus on health outcomes.
Collapse
Affiliation(s)
- John K. Jackson
- Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia
| | - Betty B. Chaar
- School of Pharmacy, University of Sydney, Sydney, NSW 2006, Australia;
| | - Carl M. Kirkpatrick
- Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia
| | - Shane L. Scahill
- School of Pharmacy, University of Auckland, Auckland 1023, New Zealand
| | - Michael Mintrom
- School of Social Sciences, Faculty of Arts, Monash University, Melbourne, VIC 3800, Australia;
| |
Collapse
|
5
|
Sailsman S, De Santis JP. Social Determinants of Health Within Nursing Curricula: Nurse Educators' Knowledge and Attitudes. J Nurs Educ 2023; 62:614-622. [PMID: 37934686 DOI: 10.3928/01484834-20230906-01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2023]
Abstract
BACKGROUND Social determinants of health (SDOH) recently have received national attention. Nursing curricula historically have focused on the mastery of clinical skills, whereas topics related to social justice and equity have been relegated to courses in community health. Little is known about nurse educators' knowledge of SDOH and attitudes about incorporating SDOH content into existing nursing curricula. This study was designed to address identified gaps in knowledge about SDOH and faculty attitudes on including SDOH content into nursing curricula. METHOD This study used a quantitative cross-sectional design. A sample of 276 nursing faculty participated in this study. Chi-square analysis and descriptive statistics were used to analyze the data. RESULTS Overall, knowledge of SDOH was high. Attitudes about including content on SDOH were favorable. Differences in knowledge and attitudes about SDOH were noted when compared by participant demographics. CONCLUSION More research is needed on effectively incorporating SDOH content into existing nursing curricula. [J Nurs Educ. 2023;62(11):614-622.].
Collapse
|
6
|
Brînzac MG, Kuhlmann E, Dussault G, Ungureanu MI, Cherecheș RM, Baba CO. Defining medical deserts-an international consensus-building exercise. Eur J Public Health 2023; 33:785-788. [PMID: 37421651 PMCID: PMC10567127 DOI: 10.1093/eurpub/ckad107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/10/2023] Open
Abstract
BACKGROUND Medical deserts represent a pressing public health and health systems challenge. The COVID-19 pandemic further exacerbated the gap between people and health services, yet a commonly agreed definition of medical deserts was lacking. This study aims to define medical deserts through a consensus-building exercise, explaining the phenomenon to its full extent, in a manner that can apply to countries and health systems across the globe. METHODS We used a standard Delphi exercise for the consensus-building process. The first phase consisted of one round of individual online meetings with selected key informants; the second phase comprised two rounds of surveys when a consensus was reached in January 2023. The first phase-the in-depth individual meetings-was organized online. The dimensions to include in the definition of medical deserts were identified, ranked and selected based on their recurrence and importance. The second phase-the surveys-was organized online. Finally, external validation was obtained from stakeholders via email. RESULTS The agreed definition highlight five major dimensions: 'Medical deserts are areas where population healthcare needs are unmet partially or totally due to lack of adequate access or improper quality of healthcare services caused by (i) insufficient human resources in health or (ii) facilities, (iii) long waiting times, (iv) disproportionate high costs of services or (v) other socio-cultural barriers'. CONCLUSIONS The five dimensions of access to healthcare: (i) insufficient human resources in health or (ii) facilities, (iii) long waiting times, (iv) disproportionate high costs of services and (v) other socio-cultural barriers-ought to be addressed to mitigate medical deserts.
Collapse
Affiliation(s)
- Monica G Brînzac
- Department of Public Health, Faculty of Political, Administrative, and Communication Sciences, Babeș-Bolyai University, Cluj-Napoca, Romania
- EUPHAnxt, European Public Health Association, Utrecht, The Netherlands
- Center for Health Workforce Research and Policy, Faculty of Political, Administrative and Communication Sciences, Babeș-Bolyai University, Cluj-Napoca, Romania
| | - Ellen Kuhlmann
- Institute of Epidemiology, Social Medicine and Health System Research, Hannover Medical School, Hannover, Germany
- Health and Health Systems, Faculty I, University of Siegen, Siegen, Germany
| | - Gilles Dussault
- Institute of Hygiene and Tropical Medicine, Lisbon, Portugal
- World Health Organization Collaborating Centre for Health Workforce Policy and Planning, Lisbon, Portugal
| | - Marius I Ungureanu
- Department of Public Health, Faculty of Political, Administrative, and Communication Sciences, Babeș-Bolyai University, Cluj-Napoca, Romania
- Center for Health Workforce Research and Policy, Faculty of Political, Administrative and Communication Sciences, Babeș-Bolyai University, Cluj-Napoca, Romania
| | - Răzvan M Cherecheș
- Department of Public Health, Faculty of Political, Administrative, and Communication Sciences, Babeș-Bolyai University, Cluj-Napoca, Romania
| | - Cătălin O Baba
- Department of Public Health, Faculty of Political, Administrative, and Communication Sciences, Babeș-Bolyai University, Cluj-Napoca, Romania
| |
Collapse
|
7
|
Adepoju OE, Kiaghadi A, Shokouhi Niaki D, Karunwi A, Chen H, Woodard L. Rethinking access to care: A spatial-economic analysis of the potential impact of pharmacy closures in the United States. PLoS One 2023; 18:e0289284. [PMID: 37498949 PMCID: PMC10374066 DOI: 10.1371/journal.pone.0289284] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2022] [Accepted: 07/14/2023] [Indexed: 07/29/2023] Open
Abstract
Data chronicling the geo-locations of all 61,589 pharmacies in the U.S. (from the Homeland Infrastructure Foundation-Level Data (HIFLD) Open Data interface, updated on April 2018) across 215,836 census block groups were combined with Medically Underserved Areas (MUAs) information, and the Centers for Disease Control and Prevention's Social Vulnerability Index (CDC-SVI). Geospatial techniques were applied to calculate the distance between the center of each census block and the nearest pharmacy. We then modeled the expected additional travel distance if the nearest pharmacy to the center of a census block closed and estimated additional travel costs, CO2 emissions, and lost labor productivity costs associated with the additional travel. Our findings revealed that MUA residents have almost two times greater travel distances to pharmacies than non-MUAs (4,269 m (2.65 mi) vs. 2,388 m (1.48 mi)), and this disparity is exaggerated with pharmacy closures (107% increase in travel distance in MUAs vs. 75% increase in travel distance in non-MUAs). Similarly, individuals living in MUAs experience significantly greater average annual economic costs than non-MUAs ($34,834 ± $668 vs. $22,720 ± $326). Our findings suggest the need for additional regulations to ensure populations are not disproportionately affected by these closures and that there is a significant throughput with community stakeholders before any pharmacy decides to close.
Collapse
Affiliation(s)
- Omolola E. Adepoju
- University of Houston College of Medicine, Houston, Texas, United States of America
- Humana Integrated Health Systems Sciences Institute, Houston, Texas, United States of America
| | - Amin Kiaghadi
- University of Houston Department of Civil and Environmental Engineering, Houston, Texas, United States of America
| | - Darya Shokouhi Niaki
- Virginia Commonwealth University Department of Biostatistics, Richmond, Virginia, United States of America
| | - Adebosola Karunwi
- University of Houston College of Medicine, Houston, Texas, United States of America
| | - Hua Chen
- University of Houston College of Pharmacy, Houston, Texas, United States of America
| | - LeChauncy Woodard
- University of Houston College of Medicine, Houston, Texas, United States of America
- Humana Integrated Health Systems Sciences Institute, Houston, Texas, United States of America
| |
Collapse
|
8
|
Hovey SW, Arif SA, Khan AM, Hyderi AF, Varughese C, Peksa GD, Flint N. More than a buzz word: Building diversity, equity, and inclusion into pharmacy residency recruitment. JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 2023. [DOI: 10.1002/jac5.1716] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Affiliation(s)
- Sara W. Hovey
- Department of Pharmacy Rush University Medical Center Chicago Illinois USA
| | - Sally A. Arif
- Department of Pharmacy Rush University Medical Center Chicago Illinois USA
- College of Pharmacy Midwestern University Downers Grove Illinois USA
| | - Ayesha M. Khan
- Department of Pharmacy Rush University Medical Center Chicago Illinois USA
| | - Alifiya F. Hyderi
- Department of Pharmacy Rush University Medical Center Chicago Illinois USA
| | - Christy Varughese
- Department of Pharmacy Rush University Medical Center Chicago Illinois USA
| | - Gary D. Peksa
- Department of Pharmacy Rush University Medical Center Chicago Illinois USA
| | - Nora Flint
- Department of Pharmacy Rush University Medical Center Chicago Illinois USA
| |
Collapse
|
9
|
Divakar A, James K, Mayorga A, Michelson KN. Availability of bereavement support following traumatic pediatric death in a large metropolitan area. DEATH STUDIES 2023:1-9. [PMID: 36708153 DOI: 10.1080/07481187.2023.2170492] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/18/2023]
Abstract
Following an unexpected pediatric death, survivors undergo unique trauma. Medical examiners (MEs) evaluate most of these deaths. We evaluated the bereavement support available to survivors in the Chicagoland area following a pediatric death. We had two goals: to characterize the available bereavement support options and compare the locations (by zip code) of support groups with the locations (by zip code) in which pediatric ME cases occurred. We identified 48 organizations that provided bereavement support services at 74 locations in the summer and fall of 2020. Locations by zip codes in which the largest number of ME cases occurred did not have support groups. Locations in which more ME cases occurred generally had lower-income populations and a greater proportion of Black or Hispanic residents. Bereavement support following pediatric death is inadequate and unevenly distributed across the Chicagoland area.
Collapse
Affiliation(s)
- Annika Divakar
- School of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
| | - K James
- Greater Illinois Pediatric Palliative Care Coalition, Chicago, Illinois, USA
- Missing Pieces, Chicago, Illinois, USA
| | - A Mayorga
- Cook County Medical Examiner's Office, Chicago, Illinois, USA
| | - K N Michelson
- School of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
- Missing Pieces, Chicago, Illinois, USA
- Critical Care, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA
| |
Collapse
|
10
|
Doyle TA, Conboy E, Halverson CME. Diagnostic deserts: Community-level barriers to appropriate genetics services. Am J Med Genet A 2023; 191:296-298. [PMID: 36282041 DOI: 10.1002/ajmg.a.63016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2022] [Accepted: 10/08/2022] [Indexed: 12/14/2022]
Affiliation(s)
- Tom A Doyle
- Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Erin Conboy
- Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Colin M E Halverson
- Indiana University School of Medicine, Indianapolis, Indiana, USA.,Charles Warren Fairbanks Center for Medical Ethics, Indianapolis, Indiana, USA
| |
Collapse
|
11
|
Morton ME, Gibson-Young L, Sandage MJ. Framing Disparities in Access to Medical Speech-Language Pathology Care in Rural Alabama. AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY 2022; 31:2847-2860. [PMID: 36327492 DOI: 10.1044/2022_ajslp-22-00025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
PURPOSE Rural-living residents of Alabama depend on rural hospitals and clinics staffed with physicians and allied health professionals including speech-language pathologists (SLPs). The purpose of the exploratory study was to examine the speech-language pathology workforce in health care facilities in nonmetropolitan Alabama counties to determine potential disparities in access and identify medical SLP deserts for rural Alabamians. METHOD The hospitals, rural health clinics, nursing homes, and rehabilitation centers for each of the 37 nonmetropolitan counties were identified through the 2020 Alabama Department of Public Health directories, and phone surveys were completed to determine medical SLP staffing at each facility. Descriptive statistics and regression analysis were conducted. RESULTS The initial review yielded 229 rural health care facilities with 223 ultimately included in the analysis and 176 facilities completing a phone inquiry (76.68%). Sixty-one (35.88%) reported employing at least one SLP and no facility stated staffing SLP assistants. Linear regression indicated a positive, yet moderate effect size between the reported number of SLPs staffed within each county and specific population of the county (r 2 = .519). Anecdotally, facilities reported difficulty in hiring and retaining SLPs due to rural geographical location. CONCLUSIONS The exploratory findings suggest disparities in access to behavioral communication and swallowing care for rural residents in the state. The methodology employed for data collection and analysis may be applied to other states and U.S. territories, in an effort to frame the issue nationally and support rural health care policy across the United States. Further investigation regarding the cost effectiveness of telepractice, the availability of broadband Internet access, the efficacy of community-based service delivery, and the effectiveness of incentivized rural SLP graduate programs is warranted to mitigate the disparities in access.
Collapse
Affiliation(s)
| | | | - Mary J Sandage
- Department of Speech, Language, and Hearing Sciences, Auburn University, AL
| |
Collapse
|
12
|
Spatial modeling of vaccine deserts as barriers to controlling SARS-CoV-2. COMMUNICATIONS MEDICINE 2022; 2:141. [DOI: 10.1038/s43856-022-00183-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2021] [Accepted: 09/07/2022] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
COVID-19 vaccine distribution is at risk of further propagating the inequities of COVID-19, which in the United States (US) has disproportionately impacted the elderly, people of color, and the medically vulnerable. We sought to measure if the disparities seen in the geographic distribution of other COVID-19 healthcare resources were also present during the initial rollout of the COVID-19 vaccine.
Methods
Using a comprehensive COVID-19 vaccine database (VaccineFinder), we built an empirically parameterized spatial model of access to essential resources that incorporated vaccine supply, time-willing-to-travel for vaccination, and previous vaccination across the US. We then identified vaccine deserts—US Census tracts with localized, geographic barriers to vaccine-associated herd immunity. We link our model results with Census data and two high-resolution surveys to understand the distribution and determinates of spatially accessibility to the COVID-19 vaccine.
Results
We find that in early 2021, vaccine deserts were home to over 30 million people, >10% of the US population. Vaccine deserts were concentrated in rural locations and communities with a higher percentage of medically vulnerable populations. We also find that in locations of similar urbanicity, early vaccination distribution disadvantaged neighborhoods with more people of color and older aged residents.
Conclusion
Given sufficient vaccine supply, data-driven vaccine distribution to vaccine deserts may improve immunization rates and help control COVID-19.
Collapse
|
13
|
Grootendorst P. Pharmacy location and medical need: regional evidence from Canada. BMC Health Serv Res 2022; 22:1309. [PMID: 36329439 PMCID: PMC9635116 DOI: 10.1186/s12913-022-08709-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2022] [Accepted: 10/13/2022] [Indexed: 11/06/2022] Open
Abstract
Background Pharmacists in Canada are assuming an increasingly important role in the provision of primary care services. This raises questions about access to pharmacy services among those with medical care needs. While there is evidence on proximity of residents of Ontario and Nova Scotia to community pharmacies, there is little evidence for the rest of Canada. I thus measured the availability of pharmacist services, both the number of community pharmacies and their hours of operation, at both the provincial and sub-provincial level in Canada. Next, I measured associations of indicators of medical need and the availability of pharmacist services across sub-provincial units. Methods I collected data, for each Forward Sortation Area (FSA), on medical need, measured using the fraction of residents aged 65 + and median household income, and pharmacist service availability (the number of community pharmacies and their hours of operation, divided by the FSA population). Linear regression methods were used to assess associations of FSA-level service availability and medical need. Results There are between 2.0 and 3.3 community pharmacies per 10,000 population, depending on the province. There are also provincial variations in the number of hours that pharmacies are open. Quebec pharmacies were open a median of 75 h a week. In Manitoba, pharmacies were open a median of 53 h a week. The per capita number of pharmacies and their total hours of operation at the FSA level tend to be higher in less affluent regions and in which the share of residents is aged 65 or older. Provincial differences in pharmacy availability were still evident after controlling for medical need. Conclusion Community pharmacies in Canada tend to locate where indicators of health needs are greatest. The impact on patient health outcomes of these pharmacy locational patterns remains an area for future research. Supplementary Information The online version contains supplementary material available at 10.1186/s12913-022-08709-5.
Collapse
Affiliation(s)
- Paul Grootendorst
- Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St, Toronto, ON, M5S3M2, Canada.
| |
Collapse
|
14
|
Wittenauer R, Shah PD, Bacci JL, Stergachis A. Pharmacy deserts and COVID-19 risk at the census tract level in the State of Washington. Vaccine X 2022; 12:100227. [PMID: 36275889 PMCID: PMC9574851 DOI: 10.1016/j.jvacx.2022.100227] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2022] [Revised: 08/12/2022] [Accepted: 10/13/2022] [Indexed: 11/02/2022] Open
Abstract
Community pharmacies are a crucial component of healthcare infrastructure, including for COVID-19 pandemic prevention services like testing and vaccination. Communities that are "pharmacy deserts," experience healthcare inequities. However, little research has characterized where these communities are, making it difficult for local leaders to prioritize resources for them. This study identifies pharmacy deserts at the census tract level in Washington state for the first time and explores their association with COVID-19 risk. Out of 1,441 tracts, 127 were pharmacy deserts, comprising approximately 454,000 adults, or 8% of the state's adult population. Among those tracts identified as pharmacy deserts, 67% were considered high risk for COVID-19. Solutions are needed to expand equitable access to pharmacy services in these communities. The methods and data presented herein provide healthcare leaders with information to address this pharmacy access gap in Washington and could be similarly applied to other settings. Three categories of policy changes could address health inequities found in our study: 1) improve financial incentives for pharmacists to practice in underserved areas, 2) prevent pharmacy closures, and 3) deploy innovative care delivery methods such as telehealth services.
Collapse
Affiliation(s)
- Rachel Wittenauer
- School of Pharmacy, CHOICE Institute, University of Washington. 1956 NE Pacific St H362, Seattle, WA 98195, USA,Corresponding author at: Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington School of Pharmacy, Seattle, WA 98195, USA.
| | - Parth D. Shah
- Hutchinson Institute for Cancer Outcomes Research (HICOR), Fred Hutch. 1100 Fairview Ave N, Seattle, WA 98109, USA
| | - Jennifer L. Bacci
- School of Pharmacy, CHOICE Institute, University of Washington. 1956 NE Pacific St H362, Seattle, WA 98195, USA
| | - Andy Stergachis
- School of Pharmacy, CHOICE Institute, University of Washington. 1956 NE Pacific St H362, Seattle, WA 98195, USA,Department of Global Health, School of Public Health, University of Washington. Hans Rosling Center, 3980 15th Ave NE, Seattle, WA 98105, USA
| |
Collapse
|
15
|
Ebinger JE, Lan R, Driver MP, Rushworth P, Luong E, Sun N, Nguyen T, Sternbach S, Hoang A, Diaz J, Heath M, Claggett BL, Bairey Merz CN, Cheng S. Disparities in Geographic Access to Cardiac Rehabilitation in Los Angeles County. J Am Heart Assoc 2022; 11:e026472. [PMID: 36073630 PMCID: PMC9683686 DOI: 10.1161/jaha.121.026472] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/28/2022] [Accepted: 07/25/2022] [Indexed: 11/16/2022]
Abstract
Background Exercise-based cardiac rehabilitation (CR) is known to reduce morbidity and mortality for patients with cardiac conditions. Sociodemographic disparities in accessing CR persist and could be related to the distance between where patients live and where CR facilities are located. Our objective is to determine the association between sociodemographic characteristics and geographic proximity to CR facilities. Methods and Results We identified actively operating CR facilities across Los Angeles County and used multivariable Poisson regression to examine the association between sociodemographic characteristics of residential proximity to the nearest CR facility. We also calculated the proportion of residents per area lacking geographic proximity to CR facilities across sociodemographic characteristics, from which we calculated prevalence ratios. We found that racial and ethnic minorities, compared with non-Hispanic White individuals, more frequently live ≥5 miles from a CR facility. The greatest geographic disparity was seen for non-Hispanic Black individuals, with a 2.73 (95% CI, 2.66-2.79) prevalence ratio of living at least 5 miles from a CR facility. Notably, the municipal region with the largest proportion of census tracts comprising mostly non-White residents (those identifying as Hispanic or a race other than White), with median annual household income <$60 000, contained no CR facilities despite ranking among the county's highest in population density. Conclusions Racial, ethnic, and socioeconomic characteristics are significantly associated with lack of geographic proximity to a CR facility. Interventions targeting geographic as well as nongeographic factors may be needed to reduce disparities in access to exercise-based CR programs. Such interventions could increase the potential of CR to benefit patients at high risk for developing adverse cardiovascular outcomes.
Collapse
Affiliation(s)
- Joseph E. Ebinger
- Department of CardiologySmidt Heart Institute, Cedars‐Sinai Medical CenterLos AngelesCA
| | - Roy Lan
- College of MedicineUniversity of Tennessee Health Science CenterMemphisTN
| | - Matthew P. Driver
- Department of CardiologySmidt Heart Institute, Cedars‐Sinai Medical CenterLos AngelesCA
| | | | - Eric Luong
- Department of CardiologySmidt Heart Institute, Cedars‐Sinai Medical CenterLos AngelesCA
| | - Nancy Sun
- Department of CardiologySmidt Heart Institute, Cedars‐Sinai Medical CenterLos AngelesCA
| | - Trevor‐Trung Nguyen
- Department of CardiologySmidt Heart Institute, Cedars‐Sinai Medical CenterLos AngelesCA
| | - Sarah Sternbach
- Department of CardiologySmidt Heart Institute, Cedars‐Sinai Medical CenterLos AngelesCA
| | - Amy Hoang
- Department of CardiologySmidt Heart Institute, Cedars‐Sinai Medical CenterLos AngelesCA
| | - Jacqueline Diaz
- Department of CardiologySmidt Heart Institute, Cedars‐Sinai Medical CenterLos AngelesCA
| | - Mallory Heath
- Department of CardiologySmidt Heart Institute, Cedars‐Sinai Medical CenterLos AngelesCA
| | | | - C. Noel Bairey Merz
- Department of CardiologySmidt Heart Institute, Cedars‐Sinai Medical CenterLos AngelesCA
| | - Susan Cheng
- Department of CardiologySmidt Heart Institute, Cedars‐Sinai Medical CenterLos AngelesCA
| |
Collapse
|
16
|
Jenkins C, Schwartz E, Onnen N, Craigmile PF, Roberts ME. Variations in Tobacco Retailer Type Across Community Characteristics: Place Matters. Prev Chronic Dis 2022; 19:E49. [PMID: 35951439 PMCID: PMC9390794 DOI: 10.5888/pcd19.210454] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Introduction The density of tobacco retailers varies by community characteristics such as poverty levels or racial and ethnic composition. However, few studies have investigated how specific types of tobacco retailers vary by community characteristics. Our objective was to assess how the types of tobacco retailers in Ohio varied by the characteristics of the communities in which they were located. Results For all US Census tracts, convenience stores were the most common type of retailer selling tobacco. Yet, the prevalence of convenience stores was higher in high-poverty urban tracts than in low-poverty urban tracts. Discount stores were the second-most common type of tobacco retailer and were most prevalent in rural tracts and high-racial and ethnic minority urban tracts. Grocery stores, pharmacies, and vape or hookah shops typically had the highest prevalence in more advantaged tracts. Conclusion Our findings demonstrate that the distribution of specific retailer types varies by community characteristics. The distribution of these retailer types has implications for product availability and price, which may subsequently affect tobacco use and cessation. To create equitable outcomes, policies should focus on retailers such as convenience and discount stores, which are heavily located in communities experiencing tobacco-related health disparities.
Collapse
Affiliation(s)
- Claire Jenkins
- College of Public Health, The Ohio State University, Columbus, Ohio
| | - Elli Schwartz
- College of Public Health, The Ohio State University, Columbus, Ohio
| | - Nathaniel Onnen
- Department of Statistics, The Ohio State University, Columbus, Ohio
| | | | - Megan E Roberts
- College of Public Health, The Ohio State University, Columbus, Ohio.,The Ohio State University, 1841 Neil Avenue, Columbus, OH 43210.
| |
Collapse
|
17
|
Pharmacy Deserts: More Than Where Pharmacies Are. J Am Pharm Assoc (2003) 2022; 62:1875-1879. [DOI: 10.1016/j.japh.2022.06.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2022] [Revised: 06/29/2022] [Accepted: 06/29/2022] [Indexed: 11/22/2022]
|
18
|
Estrada LV, Levasseur JL, Maxim A, Benavidez GA, Pollack Porter KM. Structural Racism, Place, and COVID-19: A Narrative Review Describing How We Prepare for an Endemic COVID-19 Future. Health Equity 2022; 6:356-366. [PMID: 35651360 PMCID: PMC9148659 DOI: 10.1089/heq.2021.0190] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/01/2022] [Indexed: 12/17/2022] Open
Abstract
Background: Place is a social determinant of health, as recently evidenced by COVID-19. Previous literature surrounding health disparities in the United States often fails to acknowledge the role of structural racism on place-based health disparities for historically marginalized communities (i.e., Black and African American communities, Hispanic/Latinx communities, Indigenous communities [i.e., First Nations, Native American, Alaskan Native, and Native Hawaiian], and Pacific Islanders). This narrative review summarizes the intersection between structural racism and place as contributors to COVID-19 health disparities. Methods: This narrative review accounts for the unique place-based health care experiences influenced by structural racism, including health systems and services and physical environment. We searched online databases for peer-reviewed and governmental sources, published in English between 2000 and 2021, related to place-based U.S. health inequities in historically marginalized communities. We then narrate the link between the historical trajectory of structural racism and current COVID-19 health outcomes for historically marginalized communities. Results: Structural racism has infrequently been named as a contributor to place as a social determinant of health. This narrative review details how place is intricately intertwined with the results of structural racism, focusing on one's access to health systems and services and physical environment, including the outdoor air and drinking water. The role of place, health disparities, and structural racism has been starkly displayed during the COVID-19 pandemic, where historically marginalized communities have been subject to greater rates of COVID-19 incidence and mortality. Conclusion: As COVID-19 becomes endemic, it is crucial to understand how place-based inequities and structural racism contributed to the COVID-19 racial disparities in incidence and mortality. Addressing structurally racist place-based health inequities through anti-racist policy strategies is one way to move the United States toward achieving health equity.
Collapse
Affiliation(s)
- Leah V. Estrada
- Center for Health Policy, Columbia University School of Nursing, New York, New York, USA
| | - Jessica L. Levasseur
- Nicholas School of the Environment, Duke University, Durham, North Carolina, USA
| | - Alexandra Maxim
- School of Civil and Environmental Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA
| | - Gabriel A. Benavidez
- Department of Epidemiology and Biostatistics, University of South Carolina, Columbia, South Carolina, USA
| | - Keshia M. Pollack Porter
- Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
| |
Collapse
|
19
|
An opportunity to impact public health. J Am Pharm Assoc (2003) 2022. [PMCID: PMC9076961 DOI: 10.1016/j.japh.2022.03.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
20
|
Hurley-Kim K, Unonu J, Wisseh C, Cadiz C, Knox E, Ozaki AF, Chan A. Health Disparities in Pharmacy Practice Within the Community: Let's Brainstorm for Solutions. Front Public Health 2022; 10:847696. [PMID: 35462836 PMCID: PMC9024039 DOI: 10.3389/fpubh.2022.847696] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2022] [Accepted: 02/28/2022] [Indexed: 12/02/2022] Open
Abstract
Health disparity is defined as a type of health difference that is closely linked with social, economic and/or environmental disadvantage. Over the past two decades, major efforts have been undertaken to mitigate health disparities and promote health equity in the United States. Within pharmacy practice, health disparities have also been identified to play a role in influencing pharmacists' practice across various clinical settings. However, well-characterized solutions to address such disparities, particularly within pharmacy practice, are lacking in the literature. Recognizing that a significant amount of work will be necessary to reduce or eliminate health disparities, the University of California, Irvine (UCI) School of Pharmacy and Pharmaceutical Sciences held a webinar in June 2021 to explore pertinent issues related to this topic. During the session, participants were given the opportunity to propose and discuss innovative solutions to overcome health disparities in pharmacy practice. The goal of this perspective article is to distill the essence of the presentations and discussions from this interactive session, and to synthesize ideas for practical solutions that can be translated to practice to address this public health problem.
Collapse
Affiliation(s)
- Keri Hurley-Kim
- Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, Irvine, CA, United States
| | - Jacqueise Unonu
- Department of Clinical and Administrative Pharmacy Sciences, College of Pharmacy, Howard University, Washington, DC, United States
| | - Cheryl Wisseh
- Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, Irvine, CA, United States
| | - Christine Cadiz
- Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, Irvine, CA, United States
| | - Erin Knox
- Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, Irvine, CA, United States
| | - Aya F. Ozaki
- Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, Irvine, CA, United States
| | - Alexandre Chan
- Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, Irvine, CA, United States
- *Correspondence: Alexandre Chan
| |
Collapse
|
21
|
Ding A, Dixon SW, Ferries EA, Shrank WH. The role of integrated medical and prescription drug plans in addressing racial and ethnic disparities in medication adherence. J Manag Care Spec Pharm 2022; 28:379-386. [PMID: 35199574 PMCID: PMC10372970 DOI: 10.18553/jmcp.2022.28.3.379] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Medication nonadherence in the United States contributes to 125,000 deaths and 10% of hospitalizations annually. The pain of preventable deaths and the personal costs of nonadherence are borne disproportionately by Black, Latino, and other minority groups because nonadherence is higher in these groups due to a variety of factors. These factors include socioeconomic challenges, issues with prescription affordability and convenience of filling and refilling them, lack of access to pharmacies and primary care services, difficulty taking advantage of patient engagement opportunities, health literacy limitations, and lack of trust due to historical and structural discrimination outside of and within the medical system. Solutions to address the drivers of lower medication adherence, specifically in minority populations, are needed to improve population outcomes and reduce inequities. While various solutions have shown some traction, these solutions have tended to be challenging to scale for wider impact. We propose that integrated medical and pharmacy plans are well positioned to address racial and ethnic health disparities related to medication adherence. DISCLOSURES: This study was not supported by any funding sources other than employment of all authors by Humana Inc. Humana products and programs are referred to in this article.
Collapse
|
22
|
Gervasi SS, Chen IY, Smith-McLallen A, Sontag D, Obermeyer Z, Vennera M, Chawla R. The Potential For Bias In Machine Learning And Opportunities For Health Insurers To Address It. Health Aff (Millwood) 2022; 41:212-218. [PMID: 35130064 DOI: 10.1377/hlthaff.2021.01287] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
As the use of machine learning algorithms in health care continues to expand, there are growing concerns about equity, fairness, and bias in the ways in which machine learning models are developed and used in clinical and business decisions. We present a guide to the data ecosystem used by health insurers to highlight where bias can arise along machine learning pipelines. We suggest mechanisms for identifying and dealing with bias and discuss challenges and opportunities to increase fairness through analytics in the health insurance industry.
Collapse
Affiliation(s)
| | - Irene Y Chen
- Irene Y. Chen , Massachusetts Institute of Technology, Cambridge, Massachusetts
| | | | - David Sontag
- David Sontag, Massachusetts Institute of Technology
| | - Ziad Obermeyer
- Ziad Obermeyer, University of California Berkeley, Berkeley, California
| | | | | |
Collapse
|
23
|
Javed Z, Haisum Maqsood M, Yahya T, Amin Z, Acquah I, Valero-Elizondo J, Andrieni J, Dubey P, Jackson RK, Daffin MA, Cainzos-Achirica M, Hyder AA, Nasir K. Race, Racism, and Cardiovascular Health: Applying a Social Determinants of Health Framework to Racial/Ethnic Disparities in Cardiovascular Disease. Circ Cardiovasc Qual Outcomes 2022; 15:e007917. [PMID: 35041484 DOI: 10.1161/circoutcomes.121.007917] [Citation(s) in RCA: 109] [Impact Index Per Article: 54.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Health care in the United States has seen many great innovations and successes in the past decades. However, to this day, the color of a person's skin determines-to a considerable degree-his/her prospects of wellness; risk of disease, and death; and the quality of care received. Disparities in cardiovascular disease (CVD)-the leading cause of morbidity and mortality globally-are one of the starkest reminders of social injustices, and racial inequities, which continue to plague our society. People of color-including Black, Hispanic, American Indian, Asian, and others-experience varying degrees of social disadvantage that puts these groups at increased risk of CVD and poor disease outcomes, including mortality. Racial/ethnic disparities in CVD, while documented extensively, have not been examined from a broad, upstream, social determinants of health lens. In this review, we apply a comprehensive social determinants of health framework to better understand how structural racism increases individual and cumulative social determinants of health burden for historically underserved racial and ethnic groups, and increases their risk of CVD. We analyze the link between race, racism, and CVD, including major pathways and structural barriers to cardiovascular health, using 5 distinct social determinants of health domains: economic stability; neighborhood and physical environment; education; community and social context; and healthcare system. We conclude with a set of research and policy recommendations to inform future work in the field, and move a step closer to health equity.
Collapse
Affiliation(s)
- Zulqarnain Javed
- Division of Health Equity & Disparities Research, Center for Outcomes Research, Houston Methodist, TX (Z.J., M.C.-A., K.N.)
| | | | - Tamer Yahya
- Center for Outcomes Research, Houston Methodist, TX (T.Y., I.A., J.V.-E., M.C.-A., K.N.)
| | | | - Isaac Acquah
- Center for Outcomes Research, Houston Methodist, TX (T.Y., I.A., J.V.-E., M.C.-A., K.N.)
| | - Javier Valero-Elizondo
- Center for Outcomes Research, Houston Methodist, TX (T.Y., I.A., J.V.-E., M.C.-A., K.N.).,Division of Cardiovascular Prevention and Wellness, Houston Methodist DeBakey Heart and Vascular Center, TX (J.V.-E., M.C.-A., K.N.).,Center for Cardiovascular Computational Health & Precision Medicine (C3-PH), Houston Methodist, TX (J.V.-E., M.C.-A., K.N.)
| | - Julia Andrieni
- Population Health and Primary Care (J.A.), Houston Methodist Hospital, TX
| | - Prachi Dubey
- Houston Methodist Hospital, Houston Methodist Research Institute, TX (P.D.)
| | - Ryane K Jackson
- Office of Community Benefits (R.K.J.), Houston Methodist Hospital, TX
| | - Mary A Daffin
- Barrett Daffin Frappier Turner & Engel, L.L.P., Houston, TX (M.A.D.)
| | - Miguel Cainzos-Achirica
- Division of Health Equity & Disparities Research, Center for Outcomes Research, Houston Methodist, TX (Z.J., M.C.-A., K.N.).,Center for Outcomes Research, Houston Methodist, TX (T.Y., I.A., J.V.-E., M.C.-A., K.N.).,Division of Cardiovascular Prevention and Wellness, Houston Methodist DeBakey Heart and Vascular Center, TX (J.V.-E., M.C.-A., K.N.).,Center for Cardiovascular Computational Health & Precision Medicine (C3-PH), Houston Methodist, TX (J.V.-E., M.C.-A., K.N.)
| | - Adnan A Hyder
- Milken Institute School of Public Health, George Washington University, DC (A.A.H.)
| | - Khurram Nasir
- Division of Health Equity & Disparities Research, Center for Outcomes Research, Houston Methodist, TX (Z.J., M.C.-A., K.N.).,Division of Cardiovascular Prevention and Wellness, Houston Methodist DeBakey Heart and Vascular Center, TX (J.V.-E., M.C.-A., K.N.).,Center for Cardiovascular Computational Health & Precision Medicine (C3-PH), Houston Methodist, TX (J.V.-E., M.C.-A., K.N.)
| |
Collapse
|
24
|
Zuzelo PR. Healthy Resource Deserts: Infrastructure Barriers to Addressing Holistic Health Needs. Holist Nurs Pract 2021; 35:172-174. [PMID: 33853102 DOI: 10.1097/hnp.0000000000000448] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- Patti Rager Zuzelo
- Chair, PhD in Nursing Program and DNP Project Coordinator, College of Nursing & Health Professions, Drexel University, Philadelphia, Pennsylvania
| |
Collapse
|